HighTower Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,400
Closed -$2K 2334
2018
Q4
$2K Hold
12,400
﹤0.01% 2170
2018
Q3
$2K Sell
12,400
-9,100
-42% -$177K ﹤0.01% 2245
2018
Q2
$6K Buy
21,500
+10,200
+90% +$211K ﹤0.01% 2166
2018
Q1
$6K Sell
11,300
-200
-2% -$5.53K ﹤0.01% 2111
2017
Q4
$15K Buy
11,500
+400
+4% +$10.6K ﹤0.01% 2169
2017
Q3
$10K Sell
11,100
-500
-4% -$13.3K ﹤0.01% 2149
2017
Q2
$16K Buy
+11,600
New +$245K ﹤0.01% 2086

Other funds holding EXEL

HighTower Advisors's EXEL Position: Q2 2026 in Review

HighTower Advisors increased its Exelixis (EXEL) stake by 86% in Q2 2026, buying an estimated $6.54M and bringing the position to 291,162 shares worth $15.8M. The position accounts for 0.02% of the portfolio, ranked #736.

HighTower Advisors first reported a position in EXEL in Q2 2013 and has held it in 53 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • HighTower Advisors held 291,162 shares of Exelixis worth $15.8M as of Q2 2026.
  • HighTower Advisors bought 134,397 Exelixis shares in Q2 2026, an estimated $6.54M.
  • Exelixis made up 0.02% of HighTower Advisors's portfolio in Q2 2026, its #736 holding.
  • HighTower Advisors first reported a position in Exelixis in Q2 2013 and has held it in 53 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.